Female Sexual Dysfunction Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1062186
  • May 2021
  • Medical Devices
  • 141 Pages
The global Female Sexual Dysfunction Treatment market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Female Sexual Dysfunction Treatment market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Female Sexual Dysfunction Treatment market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Female Sexual Dysfunction Treatment market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Apricus Biosciences, Inc., GlaxoSmithKline, plc., Pfizer, Inc., Merck and Co., Cipla, AMAG Pharmaceuticals Inc., Novo Nordisk AS, Sprout Pharmaceuticals Inc., Duchesnay Inc., Emotional Brain BV
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Female Sexual Dysfunction Treatment market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Female Sexual Dysfunction Treatment market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Female Sexual Dysfunction Treatment market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Female Sexual Dysfunction Treatment market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Female Sexual Dysfunction Treatment Market:
The Female Sexual Dysfunction Treatment market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Apricus Biosciences, Inc., GlaxoSmithKline, plc., Pfizer, Inc., Merck and Co., Cipla, AMAG Pharmaceuticals Inc., Novo Nordisk AS, Sprout Pharmaceuticals Inc., Duchesnay Inc., Emotional Brain BV

Female Sexual Dysfunction Treatment Market Segment Analysis:
By Type
Non-Hormonal Therapy
Hormonal Therapy


Geographic Coverage for Female Sexual Dysfunction Treatment Market:
The market research report on global Female Sexual Dysfunction Treatment market offers complete analysis across various regions across the world. The Female Sexual Dysfunction Treatment market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Female Sexual Dysfunction Treatment market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Female Sexual Dysfunction Treatment Market Value and Forecast
  • US
  • Canada
Europe Female Sexual Dysfunction Treatment Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Female Sexual Dysfunction Treatment Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Female Sexual Dysfunction Treatment Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Female Sexual Dysfunction Treatment Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Female Sexual Dysfunction Treatment market report:
  • The report provides key trends of the global Female Sexual Dysfunction Treatment market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Female Sexual Dysfunction Treatment industry
  • The report covers all the recent developments of the Female Sexual Dysfunction Treatment market and helps to provide current industry updates
  • The report covers a detailed look over the global Female Sexual Dysfunction Treatment Industry and provides with significant actionable insights
  • The Female Sexual Dysfunction Treatment market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Female Sexual Dysfunction Treatment market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Female Sexual Dysfunction Treatment market
  • Comprehensive analysis of the Female Sexual Dysfunction Treatment market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Female Sexual Dysfunction Treatment market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Female Sexual Dysfunction Treatment market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Female Sexual Dysfunction Treatment market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Female Sexual Dysfunction Treatment market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Female Sexual Dysfunction Treatment market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Apricus Biosciences, Inc.
  • GlaxoSmithKline, plc.
  • Pfizer, Inc.
  • Merck and Co.
  • Cipla
  • AMAG Pharmaceuticals Inc.
  • Novo Nordisk AS
  • Sprout Pharmaceuticals Inc.
  • Duchesnay Inc.
  • Emotional Brain BV
  • Non-Hormonal Therapy
  • Hormonal Therapy
  • Non-Hormonal Therapy
  • Hormonal Therapy

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Female Sexual Dysfunction Treatment Market Snapshot
          2.1.1. Global Female Sexual Dysfunction Treatment Market By Type,2019
               2.1.1.1.Non-Hormonal Therapy
               2.1.1.2.Hormonal Therapy
          2.1.2. Global Female Sexual Dysfunction Treatment Market By Type,2019
               2.1.2.1.Non-Hormonal Therapy
               2.1.2.2.Hormonal Therapy
          2.1.3. Global Female Sexual Dysfunction Treatment Market By End-use,2019
          2.1.4. Global Female Sexual Dysfunction Treatment Market By Geography,2019

3. Global Female Sexual Dysfunction Treatment Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Female Sexual Dysfunction Treatment Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Female Sexual Dysfunction Treatment Market Size (US$), By Type, 2018 – 2028

5. Global Female Sexual Dysfunction Treatment Market Size (US$), By Type, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Type, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Type, 2020
     5.2. Global Female Sexual Dysfunction Treatment Market Size (US$), By Type, 2018 – 2028

6. Global Female Sexual Dysfunction Treatment Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Female Sexual Dysfunction Treatment Market Size (US$), By End-use, 2018 – 2028

7. Global Female Sexual Dysfunction Treatment Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Female Sexual Dysfunction Treatment Market Analysis, 2018 – 2028 
          7.2.1. North America Female Sexual Dysfunction Treatment Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Female Sexual Dysfunction Treatment Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Female Sexual Dysfunction Treatment Market Size (US$), By Type, 2018 – 2028
          7.2.4. North America Female Sexual Dysfunction Treatment Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Female Sexual Dysfunction Treatment Market Analysis, 2018 – 2028 
          7.3.1.  Europe Female Sexual Dysfunction Treatment Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Female Sexual Dysfunction Treatment Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Female Sexual Dysfunction Treatment Market Size (US$), By Type, 2018 – 2028
          7.3.4. Europe Female Sexual Dysfunction Treatment Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Female Sexual Dysfunction Treatment Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Female Sexual Dysfunction Treatment Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Female Sexual Dysfunction Treatment Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Female Sexual Dysfunction Treatment Market Size (US$), By Type, 2018 – 2028
          7.4.4. Asia Pacific Female Sexual Dysfunction Treatment Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Female Sexual Dysfunction Treatment Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Female Sexual Dysfunction Treatment Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Female Sexual Dysfunction Treatment Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Female Sexual Dysfunction Treatment Market Size (US$), By Type, 2018 – 2028
          7.5.4. Latin America Female Sexual Dysfunction Treatment Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Female Sexual Dysfunction Treatment Market Analysis, 2018 – 2028 
          7.6.1.  MEA Female Sexual Dysfunction Treatment Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Female Sexual Dysfunction Treatment Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Female Sexual Dysfunction Treatment Market Size (US$), By Type, 2018 – 2028
          7.6.4. MEA Female Sexual Dysfunction Treatment Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Female Sexual Dysfunction Treatment Providers
        8.4.1 Apricus Biosciences, Inc.
                8.4.1.1 Business Description
                8.4.1.2 Apricus Biosciences, Inc. Geographic Operations
                8.4.1.3 Apricus Biosciences, Inc. Financial Information
                8.4.1.4 Apricus Biosciences, Inc. Product Positions/Portfolio
                8.4.1.5 Apricus Biosciences, Inc. Key Developments
        8.4.2 GlaxoSmithKline, plc.
                8.4.2.1 Business Description
                8.4.2.2 GlaxoSmithKline, plc. Geographic Operations
                8.4.2.3 GlaxoSmithKline, plc. Financial Information
                8.4.2.4 GlaxoSmithKline, plc. Product Positions/Portfolio
                8.4.2.5 GlaxoSmithKline, plc. Key Developments
        8.4.3 Pfizer, Inc.
                8.4.3.1 Business Description
                8.4.3.2 Pfizer, Inc. Geographic Operations
                8.4.3.3 Pfizer, Inc. Financial Information
                8.4.3.4 Pfizer, Inc. Product Positions/Portfolio
                8.4.3.5 Pfizer, Inc. Key Developments
        8.4.4 Merck and Co.
                8.4.4.1 Business Description
                8.4.4.2 Merck and Co. Geographic Operations
                8.4.4.3 Merck and Co. Financial Information
                8.4.4.4 Merck and Co. Product Positions/Portfolio
                8.4.4.5 Merck and Co. Key Developments
        8.4.5 Cipla
                8.4.5.1 Business Description
                8.4.5.2 Cipla Geographic Operations
                8.4.5.3 Cipla Financial Information
                8.4.5.4 Cipla Product Positions/Portfolio
                8.4.5.5 Cipla Key Developments
        8.4.6 AMAG Pharmaceuticals Inc.
                8.4.6.1 Business Description
                8.4.6.2 AMAG Pharmaceuticals Inc. Geographic Operations
                8.4.6.3 AMAG Pharmaceuticals Inc. Financial Information
                8.4.6.4 AMAG Pharmaceuticals Inc. Product Positions/Portfolio
                8.4.6.5 AMAG Pharmaceuticals Inc. Key Developments
        8.4.7 Novo Nordisk AS
                8.4.7.1 Business Description
                8.4.7.2 Novo Nordisk AS Geographic Operations
                8.4.7.3 Novo Nordisk AS Financial Information
                8.4.7.4 Novo Nordisk AS Product Positions/Portfolio
                8.4.7.5 Novo Nordisk AS Key Developments
        8.4.8 Sprout Pharmaceuticals Inc.
                8.4.8.1 Business Description
                8.4.8.2 Sprout Pharmaceuticals Inc. Geographic Operations
                8.4.8.3 Sprout Pharmaceuticals Inc. Financial Information
                8.4.8.4 Sprout Pharmaceuticals Inc. Product Positions/Portfolio
                8.4.8.5 Sprout Pharmaceuticals Inc. Key Developments
        8.4.9 Duchesnay Inc.
                8.4.9.1 Business Description
                8.4.9.2 Duchesnay Inc. Geographic Operations
                8.4.9.3 Duchesnay Inc. Financial Information
                8.4.9.4 Duchesnay Inc. Product Positions/Portfolio
                8.4.9.5 Duchesnay Inc. Key Developments
        8.4.10 Emotional Brain BV
                8.4.10.1 Business Description
                8.4.10.2 Emotional Brain BV Geographic Operations
                8.4.10.3 Emotional Brain BV Financial Information
                8.4.10.4 Emotional Brain BV Product Positions/Portfolio
                8.4.10.5 Emotional Brain BV Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Female Sexual Dysfunction Treatment Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Female Sexual Dysfunction Treatment Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Female Sexual Dysfunction Treatment Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Female Sexual Dysfunction Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Female Sexual Dysfunction Treatment Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Female Sexual Dysfunction Treatment Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Female Sexual Dysfunction Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Female Sexual Dysfunction Treatment Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Female Sexual Dysfunction Treatment Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Female Sexual Dysfunction Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Female Sexual Dysfunction Treatment Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Female Sexual Dysfunction Treatment Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Female Sexual Dysfunction Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Female Sexual Dysfunction Treatment Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Female Sexual Dysfunction Treatment Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Female Sexual Dysfunction Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Female Sexual Dysfunction Treatment: Market Segmentation 
FIG. 2 Global Female Sexual Dysfunction Treatment Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Female Sexual Dysfunction Treatment Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Female Sexual Dysfunction Treatment Market, By Type, 2019 (US$ Mn) 
FIG. 6 Global Female Sexual Dysfunction Treatment Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Female Sexual Dysfunction Treatment Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Female Sexual Dysfunction Treatment Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Female Sexual Dysfunction Treatment Providers, 2019
FIG. 11 Global Female Sexual Dysfunction Treatment Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Female Sexual Dysfunction Treatment Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 13 Global Female Sexual Dysfunction Treatment Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Female Sexual Dysfunction Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Female Sexual Dysfunction Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Female Sexual Dysfunction Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Female Sexual Dysfunction Treatment Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Female Sexual Dysfunction Treatment Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Female Sexual Dysfunction Treatment market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Female Sexual Dysfunction Treatment Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Female Sexual Dysfunction Treatment Market Value, By Segment1, 2018 – 2028
TABLE  North America Female Sexual Dysfunction Treatment Market Value, By Segment2, 2018 – 2028
TABLE  North America Female Sexual Dysfunction Treatment Market Value, By Country, 2018 – 2028
TABLE  Europe Female Sexual Dysfunction Treatment Market Value, By Segment1, 2018 – 2028
TABLE  Europe Female Sexual Dysfunction Treatment Market Value, By Segment2, 2018 – 2028
TABLE  Europe Female Sexual Dysfunction Treatment Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Female Sexual Dysfunction Treatment Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Female Sexual Dysfunction Treatment Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Female Sexual Dysfunction Treatment Market Value, By Country, 2018 – 2028
TABLE  Latin America Female Sexual Dysfunction Treatment Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Female Sexual Dysfunction Treatment Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Female Sexual Dysfunction Treatment Market Value, By Country, 2018 – 2028
TABLE  MEA Female Sexual Dysfunction Treatment Market Value, By Segment1, 2018 – 2028
TABLE  MEA Female Sexual Dysfunction Treatment Market Value, By Segment2, 2018 – 2028
TABLE  MEA Female Sexual Dysfunction Treatment Market Value, By Country, 2018 – 2028
TABLE  Apricus Biosciences, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline, plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck and Co.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cipla: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AMAG Pharmaceuticals Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novo Nordisk AS: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sprout Pharmaceuticals Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Duchesnay Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Emotional Brain BV: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Female Sexual Dysfunction Treatment Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Female Sexual Dysfunction Treatment Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Female Sexual Dysfunction Treatment Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Female Sexual Dysfunction Treatment Market, By Geography, 2019 (US$ Mn)
FIG.  Global Female Sexual Dysfunction Treatment Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Female Sexual Dysfunction Treatment Providers, 2016
FIG.  Global Female Sexual Dysfunction Treatment Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Hormonal Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Female Sexual Dysfunction Treatment Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Hormonal Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Female Sexual Dysfunction Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Female Sexual Dysfunction Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Female Sexual Dysfunction Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Female Sexual Dysfunction Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Female Sexual Dysfunction Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Female Sexual Dysfunction Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Female Sexual Dysfunction Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Female Sexual Dysfunction Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Female Sexual Dysfunction Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Female Sexual Dysfunction Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Female Sexual Dysfunction Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Female Sexual Dysfunction Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Female Sexual Dysfunction Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Female Sexual Dysfunction Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Female Sexual Dysfunction Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Female Sexual Dysfunction Treatment Market Value, 2018 – 2028, (US$ Mn)